MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 4mg modified-release tablets (Pfizer Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 8mg modified-release tablets (Pfizer Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Zebinix 800mg tablets (BIAL Pharma UK Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 4mg modified-release tablets (Pfizer Ltd).

Stability Notes

Protect from moisture.

Provenance

This compatibility recommendation is derived from Toviaz 8mg modified-release tablets (Pfizer Ltd).

Stability Notes

Designed for sublingual administration.

Provenance

This compatibility recommendation is derived from Abstral sublingual tablets (Kyowa Kirin Ltd).

Stability Notes

Designed for sublingual administration.

Provenance

This compatibility recommendation is derived from Abstral sublingual tablets (Kyowa Kirin Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.